Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
EPS Over TimeExpanding
Percentile Rank55
5Y CAGR-18.0%
Studio
Year-over-Year Change

Earnings per share

5Y CAGR
-18.0%/yr
Long-term compound
Percentile
P55
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
20250.23+160.5%
2024-0.38+20.8%
2023-0.48+44.2%
2022-0.86-1328.6%
20210.07-88.7%
20200.62+113.6%
2019-4.57-243.6%
2018-1.33-191.1%
20171.46+32.7%
20161.10-